Skip to main content
Top
Published in: Neurological Sciences 12/2020

01-12-2020 | Torticollis Spasticus | Brief Communication

A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability

Authors: Manuel Delgado-Alvarado, Antoni Matilla-Dueñas, Antonio Altadill-Bermejo, Sonia Setién, Mercedes Misiego-Peral, José Ramón Sánchez-de la Torre, Marc Corral-Juan, Javier Riancho

Published in: Neurological Sciences | Issue 12/2020

Login to get access

Abstract

Myoclonus-dystonia associated with epsilon-sarcoglycan gene (SGCE) is a rare disorder characterized by myoclonus involving the upper body (neck, trunk, upper limbs) and proximal muscles associated with dystonia in more than half of the patients. When the clinical picture is clearly identified, more than half of the cases are associated with mutations in the SGCE gene. We herein describe a family with myoclonus-dystonia associated with a novel mutation in exon 7 of SGCE, c.904A>T (p.Lys302Ter) [Chr7:(GRCh38):g.94600779 T>A], which was absent in a non-affected member. A video recording of two of the affected members is provided. While the index case presents a severe cervical dystonia even affecting back posture, his sibling shows a much milder phenotype with mild myoclonic jerks. None of them had alcohol responsiveness or psychiatric comorbidity.
Appendix
Available only for authorised users
Literature
2.
go back to reference Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Müller-Myhsok B, Riedel L, Bauer M, Müller T, Castro M, Meitinger T, Strom TM, Gasser T (2001) Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29:66–69. https://doi.org/10.1038/ng709CrossRefPubMed Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Müller-Myhsok B, Riedel L, Bauer M, Müller T, Castro M, Meitinger T, Strom TM, Gasser T (2001) Mutations in the gene encoding ε-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29:66–69. https://​doi.​org/​10.​1038/​ng709CrossRefPubMed
3.
go back to reference Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C (2016) Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord 31:436–457CrossRef Marras C, Lang A, van de Warrenburg BP, Sue CM, Tabrizi SJ, Bertram L, Mercimek-Mahmutoglu S, Ebrahimi-Fakhari D, Warner TT, Durr A, Assmann B, Lohmann K, Kostic V, Klein C (2016) Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord 31:436–457CrossRef
6.
go back to reference Menozzi E, Balint B, Latorre A, Valente EM, Rothwell JC, Bhatia KP (2019) Twenty years on: Myoclonus-dystonia and ε-sarcoglycan — neurodevelopment, channel, and signaling dysfunction. Mov Disord 34:1588–1601CrossRef Menozzi E, Balint B, Latorre A, Valente EM, Rothwell JC, Bhatia KP (2019) Twenty years on: Myoclonus-dystonia and ε-sarcoglycan — neurodevelopment, channel, and signaling dysfunction. Mov Disord 34:1588–1601CrossRef
7.
go back to reference Timmers ER, Peall KJ, Dijk JM, Zutt R, Tijssen CC, Bergmans B, Foncke EM, Tijssen MAJ (2020) Natural course of myoclonus-dystonia in adulthood: stable motor signs but increased psychiatry. Mov Disord 35:1077–1078CrossRef Timmers ER, Peall KJ, Dijk JM, Zutt R, Tijssen CC, Bergmans B, Foncke EM, Tijssen MAJ (2020) Natural course of myoclonus-dystonia in adulthood: stable motor signs but increased psychiatry. Mov Disord 35:1077–1078CrossRef
9.
go back to reference Grünewald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, Papengut F, Petersen B, Fung V, Sue CM, O'Sullivan D, Mahant N, Kupsch A, Chuang RS, Wiegers K, Pawlack H, Hagenah J, Ozelius LJ, Stephani U, Schuit R, Lang AE, Volkmann J, Münchau A, Klein C (2008) Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 29:331–332. https://doi.org/10.1002/humu.9521CrossRefPubMed Grünewald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, Papengut F, Petersen B, Fung V, Sue CM, O'Sullivan D, Mahant N, Kupsch A, Chuang RS, Wiegers K, Pawlack H, Hagenah J, Ozelius LJ, Stephani U, Schuit R, Lang AE, Volkmann J, Münchau A, Klein C (2008) Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 29:331–332. https://​doi.​org/​10.​1002/​humu.​9521CrossRefPubMed
11.
go back to reference Müller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C (2002) Evidence that paternal expression of the ε-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71:1303–1311. https://doi.org/10.1086/344531CrossRefPubMedPubMedCentral Müller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C (2002) Evidence that paternal expression of the ε-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71:1303–1311. https://​doi.​org/​10.​1086/​344531CrossRefPubMedPubMedCentral
Metadata
Title
A novel SGCE variant is associated with myoclonus-dystonia with phenotypic variability
Authors
Manuel Delgado-Alvarado
Antoni Matilla-Dueñas
Antonio Altadill-Bermejo
Sonia Setién
Mercedes Misiego-Peral
José Ramón Sánchez-de la Torre
Marc Corral-Juan
Javier Riancho
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 12/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04718-6

Other articles of this Issue 12/2020

Neurological Sciences 12/2020 Go to the issue